Fiche publication


Date publication

février 2016

Journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr BOLOGNA Serge


Tous les auteurs :
Lepretre S, Touzart A, Vermeulin T, Picquenot JM, Tanguy-Schmidt A, Salles G, Lamy T, Béné MC, Raffoux E, Huguet F, Chevallier P, Bologna S, Bouabdallah R, Benichou J, Brière J, Moreau A, Tallon-Simon V, Seris S, Graux C, Asnafi V, Ifrah N, Macintyre E, Dombret H

Résumé

This study evaluated the efficacy of pediatric-like acute lymphoblastic leukemia (ALL) therapy in adults with lymphoblastic lymphoma (LL).

Mots clés

Adolescent, Adult, Antineoplastic Combined Chemotherapy Protocols, therapeutic use, Cell Cycle Proteins, genetics, Central Nervous System Diseases, etiology, Consolidation Chemotherapy, methods, Disease-Free Survival, F-Box Proteins, genetics, Female, Hematopoietic Stem Cell Transplantation, Humans, Induction Chemotherapy, methods, L-Lactate Dehydrogenase, blood, Maintenance Chemotherapy, methods, Male, Middle Aged, PTEN Phosphohydrolase, genetics, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, drug therapy, Precursor Cell Lymphoblastic Leukemia-Lymphoma, drug therapy, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, drug therapy, Prospective Studies, Receptor, Notch1, genetics, Recurrence, Survival Rate, Treatment Outcome, Ubiquitin-Protein Ligases, genetics, Young Adult, ras Proteins, genetics

Référence

J. Clin. Oncol.. 2016 Feb;34(6):572-80